Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>M Stanley Ratings, TPs on Biotechs (Table)
Recommend 48 Positive 52 Negative 26 |
||||
|
||||
|
Stock | Rating | TP (HK$) VISEN PHARMA-B(02561.HK) | Outperform | 80 AKESO(09926.HK) | Outperform | 87->215 Zai Lab (ZLAB.US) | Outperform | US$48 ZAI LAB(09688.HK) | Outperform | 37.5 INNOVENT BIO(01801.HK) | Outperform | 67-> 123 KEYMED BIO-B(02162.HK) | Outperform | 56 -> 93.5 ABBISKO-B(02256.HK) | Outperform | 8.3->22 DUALITYBIO-B(09606.HK) | Outperform | 244->493 INNOCARE(09969.HK) | Equalweight | 8.25->19.6 LEADS BIOLABS-B(09887.HK) | Equalweight | 59 EVEREST MED(01952.HK) | Equalweight | 40->55 REMEGEN(09995.HK) | Equalweight | 16-> 89 HUTCHMED (China) (HCM.US) | Equalweight ->Underweight | US$18->US$13.75 HUTCHMED(00013.HK) | Equalweight ->Underweight | 28-> 21.4 AAStocks Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
